B. Stach
YOU?
Author Swipe
View article: Symptomatic response to CPAP in obstructive sleep apnea versus COPD- obstructive sleep apnea overlap syndrome: Insights from a large national registry
Symptomatic response to CPAP in obstructive sleep apnea versus COPD- obstructive sleep apnea overlap syndrome: Insights from a large national registry Open
Background The symptomatic response to continuous positive airway pressure (CPAP) therapy in COPD-obstructive sleep apnea overlap syndrome (OVS) compared to OSA syndrome (OSA) alone has not been well studied so far. The aim of this study i…
View article: Management of acute COPD exacerbations in France: A qualitative survey in a private practice setting
Management of acute COPD exacerbations in France: A qualitative survey in a private practice setting Open
Background The current prevalence of chronic obstructive pulmonary disease (COPD) in France is estimated to be 2.6 million and is predicted to increase to 2.8 million by 2025. Presently, there is a lack of data on COPD management within th…
View article: Symptomatic response to CPAP in obstructive sleep apnea versus COPD- obstructive sleep apnea overlap syndrome: Insights from a large national registry
Symptomatic response to CPAP in obstructive sleep apnea versus COPD- obstructive sleep apnea overlap syndrome: Insights from a large national registry Open
Background: The symptomatic response to continuous positive airway pressure (CPAP) therapy in COPD-obstructive sleep apnea overlap syndrome (OVS) compared to OSA syndrome (OSA) alone has not been well studied so far. The aim of this study…
View article: Clinical presentation and comorbidities of obstructive sleep apnea-COPD overlap syndrome
Clinical presentation and comorbidities of obstructive sleep apnea-COPD overlap syndrome Open
In adults with moderate-to-severe OSA, OVS was minimally symptomatic, but exhibited higher odds for prevalent coronary heart disease, heart failure and peripheral arteriopathy.
View article: The Somatotropic Axis in the Sleep Apnea-Obesity Comorbid Duo
The Somatotropic Axis in the Sleep Apnea-Obesity Comorbid Duo Open
Background: Growth hormone (GH) stimulates the production of insulin-like growth factor 1 (IGF-1) in most tissues and together GH and IGF-1 profoundly impact adipose tissue deposition, glucose metabolism and cardiovascular function. A low …
View article: Acromegaly in sleep apnoea patients: a large observational study of 755 patients
Acromegaly in sleep apnoea patients: a large observational study of 755 patients Open
Acromegaly is a rare, chronic and progressive disease characterised by excess secretion of growth hormone with raised insulin-like growth factor I (IGF-I) levels and usually caused by a pituitary adenoma [1, 2]. Its prevalence is estimated…
View article: Obstructive Sleep Apnea: A Cluster Analysis at Time of Diagnosis
Obstructive Sleep Apnea: A Cluster Analysis at Time of Diagnosis Open
Our cluster analysis identified six distinct clusters of obstructive sleep apnea. Our findings underscore the high degree of heterogeneity that exists within obstructive sleep apnea patients regarding clinical presentation, risk factors an…
View article: IGF-1: A marker of cardio-metabolic risk in obstructive sleep apnea (OSA) syndrome?
IGF-1: A marker of cardio-metabolic risk in obstructive sleep apnea (OSA) syndrome? Open
Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
View article: Prevalence of acromegaly in patients referred for sleep apnea syndrome (SAS): results of ACROSAS Study
Prevalence of acromegaly in patients referred for sleep apnea syndrome (SAS): results of ACROSAS Study Open
Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | ISSN 1479-6848 (online)